Article
High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.
Oncology reports - 1 May 2017
Li Wei-Qing, Zhong Nan-Zhe, He Jin, Li Yi-Ming, Hou Li-Jun, Liu Hui-Min, Xia Chun-Yan, Wang Liang-Zhe, Lu Yi-Cheng
Abstract excerpt
Novel molecular markers are required for defining subsets of diffuse astrocytic tumor patients with differing prognoses. Here, we examined ATP2A2 expression in 109 human diffuse astrocytic tumor samples (39 grade II diffuse astrocytoma (DA), 19 grade III anaplastic astrocytoma (AA), 51 grade IV glioblastoma) and its correlation with patient clinicopathologic characteristics. ATP2A2 expression significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.